Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathology of multiple sclerosis: some new developments

E P Richardson1

  • 1Laboratory for Neuropathology, Massachusetts General Hospital, Boston 02114-2696, USA.

Clinical Neuroscience (New York, N.Y.)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Vascular Access Questionnaire: assessing patient-reported views of vascular access.

The journal of vascular access·2008
Same author

Home care assistance and the utilization of peritoneal dialysis.

Kidney international·2007
Same author

The neurologic illness of Eugene O'Neill--a clinicopathological report.

The New England journal of medicine·2000
Same author

Clinical, neuropathological and genetic aspects of the tuberous sclerosis complex.

Brain pathology (Zurich, Switzerland)·1995
Same author

The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system.

Brain pathology (Zurich, Switzerland)·1995
Same author

An improved approach to prepare human brains for research.

Journal of neuropathology and experimental neurology·1995
Same journal

Cardiovascular autonomic dysfunction in parkinsonian patients.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Visuo-cognitive dysfunctions in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Gastrointestinal dysfunction in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Respiratory function in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Neurophysiology of sensorimotor integration in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Imaging of nonmotor symptoms in Parkinson syndromes.

Clinical neuroscience (New York, N.Y.)·2000
See all related articles

Neuropathology in multiple sclerosis (MS) involves immune cell activity and damage to the myelin sheath, not the oligodendrocyte. While remyelination occurs, it is ineffective, leaving many questions unanswered.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease characterized by damage to the central nervous system.
  • Understanding the neuropathology of MS is crucial for developing effective treatments.

Purpose of the Study:

  • To review current investigations into the neuropathology of multiple sclerosis (MS).
  • To highlight the role of immunocytochemical methods and electron microscopy in studying MS lesions.
  • To discuss the current understanding and remaining questions regarding the demyelination process and oligodendrocyte status in MS.

Main Methods:

  • Immunocytochemical methods to identify cellular activities, especially immune cells, in MS lesions.
  • Electron microscopy to complement immunocytochemical observations.

Related Experiment Videos

  • Review of existing literature on MS neuropathology.

    • Main Results:

    • The blood-brain barrier is identified as the site of initial pathologic events, though the trigger remains unknown.
    • Evidence suggests the myelin sheath is the primary target in the demyelinative process, rather than the oligodendrocyte.
    • Remyelination is observed in early MS lesions but is ultimately ineffective.

    Conclusions:

    • The precise mechanism initiating blood-brain barrier opening in MS requires further investigation.
    • The status of oligodendrocytes in MS is still uncertain, with some surviving the disease process.
    • Despite ongoing research, many neuropathologic aspects of MS remain unanswered, necessitating further study.